Medical decisions are being made not only by insurance companies but also by hospital managers and algorithms, and concern for patient care continues to grow.
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.
A new and developing force in medicine will add a new set of dramatic changes: the force of consumerism. No longer will you, as a patient, be willing to be “patient.”